On November 22, it was reported that according to the documents disclosed by the Hong Kong Stock Exchange on November 22, citic sec asset management company increased its shareholding on November 20 at an average price of HKD 21.2104 per share.$SINOPHARM (01099.HK)$An additional 2.322 million H shares were added, valued at approximately HKD 49.2505 million. After the increase, the latest shareholding number of citic sec asset management company is 68.0352 million shares, and the good warehouse ratio has increased from 4.90% to 5.07%.
This trade involves other related parties: citic sec - Yunfan single asset management plan.
Additional information: The equity is held by citic sec asset management company on behalf of all the asset management plans it manages, disclosing the shares of sinopharm holdings limited - H share equity.
What is equity disclosure?
According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.
Why is equity disclosure important?
Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.
